We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Stemina Awarded $10 Million EPA Contract
News

Stemina Awarded $10 Million EPA Contract

Stemina Awarded $10 Million EPA Contract
News

Stemina Awarded $10 Million EPA Contract

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Stemina Awarded $10 Million EPA Contract"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The contract will generate up to $10,637,000 in revenue for Stemina over the next 5 years. Under the contract, Stemina will screen drugs and chemicals, using its devTOX toxicology tests, for their potential to cause birth defects if a woman is exposed during pregnancy. “The EPA’s ToxCast initiative is the preeminent collection of toxicology information on a broad range of chemicals,” said Elizabeth Donley, CEO of Stemina. “As the only provider of an all human system designed to assess the potential for drugs and chemicals to cause birth defects, we are proud to have our devTOX tests included in this program. Our tests will provide valuable information about the impact that various classes of compounds can have on the developing human embryo.” 

Stemina’s cell based tests arise from the strategic convergence of two cutting edge technologies: stem cells and metabolomics. Stemina has published on its devTOX assays in peer reviewed scientific journals since 2009 and is a recognized leader in human stem cell based toxicology. 

ToxCast is a multi-year effort launched in 2007 at the EPA that uses automated chemical screening technologies (called "high-throughput screening assays") to expose living cells or isolated proteins to chemicals. The cells or proteins are then screened for changes in biological activity that may suggest potential toxic effects and eventually potential adverse health effects. These innovative methods have the potential to limit the number of required laboratory animal-based toxicity tests while quickly and efficiently screening large numbers of chemicals. 

ToxCast has evaluated over 2,000 chemicals from a broad range of sources including: industrial and consumer products, food additives, and potentially "green" chemicals that could be safer alternatives to existing chemicals.

Advertisement